TRASTUZUMAB EMTANSINE for Her2 positive breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where TRASTUZUMAB EMTANSINE was used for Her2 positive breast cancer.
Most Reported Side Effects for TRASTUZUMAB EMTANSINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 38 | 20.8% | 0 | 26 |
| Disease progression | 20 | 10.9% | 9 | 10 |
| Platelet count decreased | 16 | 8.7% | 1 | 12 |
| Metastases to central nervous system | 11 | 6.0% | 4 | 4 |
| Pneumonia | 7 | 3.8% | 3 | 7 |
| Thrombocytopenia | 7 | 3.8% | 4 | 4 |
| Anaemia | 6 | 3.3% | 1 | 5 |
| Decreased appetite | 6 | 3.3% | 1 | 4 |
| Hepatic function abnormal | 6 | 3.3% | 0 | 4 |
| Aspartate aminotransferase increased | 5 | 2.7% | 0 | 4 |
| Nausea | 5 | 2.7% | 3 | 5 |
| Pyrexia | 5 | 2.7% | 1 | 5 |
Other Indications for TRASTUZUMAB EMTANSINE
Breast cancer (80)
Breast cancer metastatic (49)
Her-2 positive breast cancer (19)
Neoplasm malignant (5)
Other Drugs Used for Her2 positive breast cancer
TRASTUZUMAB (5,549)
PERTUZUMAB (3,037)
DOCETAXEL (1,672)
FAM-TRASTUZUMAB DERUXTECAN-NXKI (1,578)
ADO-TRASTUZUMAB EMTANSINE (1,521)
CAPECITABINE (1,421)
PACLITAXEL (1,108)
TUCATINIB (993)
TRASTUZUMAB DERUXTECAN (768)
CYCLOPHOSPHAMIDE (610)